Yongin, South Korea

Ho-Woong Kang

This inventor holds 19 USPTO granted patents and 8 published patent applications, plus 1 CIPO patent and 6 EPO patents. Top assignees: Samsung Electronics Co., Ltd., Yuhan Corporation. Active years: 2002-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ho-Woong Kang. Retrieved from https://idiyas.com/inventor/ho-woong-kang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 19 

% Patents Active = 52.6


 

Average Co-Inventor Count = 1.6

ph-index = 3

Forward Citations = 27(Granted Patents)


Location History:

  • Yorigin, KR (2002)
  • Youngin, KR (2006 - 2008)
  • Gyeonggi-do, KR (2019)
  • Yongin-si, KR (2010 - 2021)

Company Filing History:


Years Active: 2002-2021

Loading Chart...
Loading Chart...
Loading Chart...
19 patents (USPTO):Explore Patents

Title: The Innovative Mind of Ho-Woong Kang

Introduction

Ho-Woong Kang is a remarkable inventor based in Yongin-si, South Korea, known for his groundbreaking contributions to the field of pharmaceuticals. With a total of 19 patents to his name, Kang has focused on developing innovative compounds that hold the potential for significant advancements in cancer treatment.

Latest Patents

Kang's latest patents reflect his commitment to enhancing cancer treatment options. One of his notable inventions is a quinazoline derivative or its salt, along with a pharmaceutical composition comprising the same. This invention provides a selective inhibitory activity against the phosphatidylinositol 3-kinase delta subunit, which is crucial for cancer treatment while minimizing side effects, such as lymphopenia-associated inflammatory responses.

Another significant patent developed by Kang is a benzo[d]thiazole derivative or its salt, including a pharmaceutical composition associated with it. This derivative selectively inhibits the interaction between the KRS protein and the laminin receptor, effectively inhibiting the migration of cancer cells. This compound holds promise for preventing and treating diseases associated with cancer cell metastasis, showcasing Kang's innovative approach to combating cancer.

Career Highlights

Throughout his career, Ho-Woong Kang has made notable contributions while working at esteemed companies, including Samsung Electronics Co., Ltd. and Yuhan Corporation. His experiences in these organizations have provided him with a strong foundation to pursue his inventions and advancements in pharmaceutical sciences.

Collaborations

Kang has had the pleasure of collaborating with talented coworkers such as Hoon Moo Choi and Jin-sung Kang. These collaborative efforts have likely contributed to the innovative and impactful nature of his work, driving significant advancements in the pharmaceutical field.

Conclusion

Ho-Woong Kang stands out as a prolific inventor dedicated to revolutionizing cancer treatment through his innovative inventions. His latest patents exhibit a keen understanding of complex biological mechanisms and a commitment to improving patient outcomes. As research and development in this field continue, Kang's work may pave the way for groundbreaking pharmaceutical solutions in the fight against cancer.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…